Human Epidermal Growth Factor Receptor 2 - Globe Thesis

Keyword [Human Epidermal Growth Factor Receptor 2] Result: 81 - 95 \| Page: 5 of 5
81.	Prognostic Analysis Of The Patients With HER-2 Positive Early Breast Cancer
82.	Predictive Value Of HER2 Low Expression On The Outcome And Recurrence Of Metastasis In Triple Negative Early/locally Advanced Breast Cancer Patients
83.	Clinicopathological Characteristics Of HER2 Low Expression Breast Cancer And Factors Influencing Its Efficacy With Neoadjuvant Chemotherapy
84.	Prognosis And Clinicopathological Parameters Of Human Epidermal Growth Factor Receptor 2 In Relation To Patients With Gastric Or Gastroesophageal Junction Cancer:a Meta-analysis
85.	A Real-world Study Of Pyrotinib In The Treatment Of HER2-positive Advanced Breast Cancer
86.	Classification Of Breast Edema On T2-weighted Imaging For Predicting Sentinel Lymph Node Metastasis And Biological Behavior In Breast Cancer
87.	Clinical Study On The Recurrence Risk Of HR+/HER2+ Breast Cancer And The Pathology And Prognosis Of Its Single-hormone Receptor Positive Subtypes
88.	Evaluation And Clinical Significance Of Circulating Tumor Cells And Circulating Tumor Cell HER-2 Detection In Breast Cancer Neoadjuvant Chemotherapy
89.	Efficacy And Safety Of Pyrotinib-Based Regimens In HER2 Positive Metastatic Breast Cancer:A Retrospective Real-World Data Study
90.	Clinicopathological Features And Prognostic Analysis Of The Breast Cancer With Low HER-2 Expression
91.	The Experimental Study Of HSV-TK Gene Delivery Mediated By HER2 Targeted Fluorocarbon Nanodroplets Combined With Low Intensity Focused-ultrasound On Gastric Carcinoma Xenograft In Nude Mice
92.	Long-term Outcomes By Neoadjuvant Efficacy Indexes In HR+ And HR+/HER2+ Breast Cancer:A Systematic Review And Meta-analysis
93.	Experimental Study Of HER2 Targeted Lipid Nanobubbles Carrying HSV-TK Suicide Gene Combined With Ultrasound Targeted Microbubble Destruction Technology On Transplanted Tumor Of Gastric Cancer In Nude Mice
94.	An Integrated Experimental Study On Diagnosis And Treatment Of Ovarian Cancer Based On ^99mTc And ¹³¹I Labeled HER2 Affibody
95.	Clinicopathological Characteristics And Prognosis Of Human Epidermal Growth Factor Receptor 2-low Breast Cancer
<<First <Prev Next> Last>> Jump to